Letter

Regulation’s threat to research

Over-regulation, Russian style

BMJ 2009; 338 doi: 10.1136/bmj.a3141 (Published 6 January 2009)
Cite this as: BMJ 2009;338:a3141

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Vasiliy V Vlassov, professor1
  1. 1Moscow Medical Academy, Trubetskaya 8, Moscow, 101000 Russia
  1. vlassov{at}cochrane.ru

    Bureaucratic and ethical control that damages research is not limited to the United Kingdom.1

    When ethical control of applications for clinical trials was introduced in Russia many years ago, the federal law on drugs stated that only drug developers can …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular